It looks to me that Kimberly Clark (UK) are targeting the $3B transdermal patch market using imprint technology in a new development program with imprint supplier – Obducat (Sweden). Kimberly-Clark is ...

Daytrana (methylphenidate) is a brand-name drug prescribed for ADHD in certain children. Daytrana comes as a transdermal patch that’s typically applied once per day for up to 9 hours. The dosage can ...

UNIVEC and 11 Three launch RELIEFTA™, an advanced transdermal pain patch using patented SENDS™ nano-technology out of ...

As consumer attention around transdermal wellness patches grows in 2026, interest has also expanded around ingredient visibility, product variety, and policy transparency across the category. This ...

Mylan Pharmaceutical's ($MYL) Xulane is the first generic contraceptive transdermal patch to hit the market, marking another milestone for the delivery technology ...

Midlife wellness for women has received growing attention in recent years. Women’s health research has received increased funding, and the supplement market has exploded with products promising ...

Corsair Pharma, Inc., a private biopharmaceutical company, today announced three presentations related to its clinical program at the Pulmonary Hypertension Association (PHA) meeting taking place June ...

Eight years ago, I wrote about a startup trying to deliver cancer drugs through the skin. That company is long gone, but is the market for so-called transdermal (across the skin) drug delivery a good ...

Daytrana (methylphenidate) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). It comes as a transdermal patch that’s usually applied to the skin once per day.